TCMD INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Announces the Filing of Investor Class Action Lawsuit against Tactile Systems Technology (TCMD) for Defrauding Investors through Illegal Sales and Marketing Scheme
CureVac: CureVac Initiates Phase 2a Clinical Trial of COVID-19 Vaccine Candidate
DuraSorb® Monofilament Mesh Earns CE Mark Approval
Adial Pharmaceuticals Announces COVID-19 Point-of-Care Antibody Test Granted First Ever FDA Emergency Use Authorization for Use with Fingerstick Blood Samples
American Kidney Fund Expands Rare Disease Initiatives with Education and Awareness Campaign About Fabry Disease
SAN FRANCISCO–(BUSINESS WIRE)–$TCMD #NASDAQ–Today, leading shareholder rights law firm Hagens Berman filed a securities fraud…
Study conducted in Peru and Panama Trial involves 690 participants, including older adults Evaluation of…
Best-in-class soft tissue support product soon available in Europe for Abdominal Wall, Cosmetic, and Reconstructive…
CHARLOTTESVILLE, VA / ACCESSWIRE / September 29, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a…
Campaign explores Fabry disease as a cause of unexplained chronic kidney disease and empowers people…
TORONTO, ON / ACCESSWIRE / September 29, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC), a…
Recent Acquition Fuels Unprecedented Growth for Holding Company TULSA, OK / ACCESSWIRE / September 29…
EDISON, NJ / ACCESSWIRE / September 29, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical…
SEOUL, KOREA / ACCESSWIRE / September 29, 2020 / As of the 26th of August…
VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / September 29, 2020 / Imagin Medical (CSE:IME)(OTCQB:IMEXF)(Frankfurt &…
